🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Kraken Seattle Kraken and Virginia Mason Franciscan Health VirginiaMasonUrology team up to promote prostate cancer screening and awareness youtu.be/RKOioOIODeE?fe…

We love having the Madigan urology residents rotate with us at VirginiaMasonUrology. Tim’s last day on service! He did a stellar job 🌟

BCG Unresponsive Cancer in 2024 Ashish M. Kamat, MD, MBBS at the #SUO24 Bladder Cancer Course Bladder-sparing therapy for BCR-UR NMBIC: IBCG Recommendations for Optimal Sequencing and Patient Selection UroToday.com

Finally in press! And here’s the tweetorial on it 👇 x.com/adam_weiner535…

Excellent work by ⁦⁦⁦Savannah Starr, MD⁩ Insurance remains a major source of disparity for patients with testicular cancer: call for advocacy - Starr - BJU International - Wiley Online Library bjui-journals.onlinelibrary.wiley.com/doi/10.1111/bj…

Novel delivery mechanisms for existing systemic agents and emerging therapies in #BladderCancer. Bladder cancer treatment is rapidly evolving, with new delivery mechanisms enhancing the efficacy of existing therapies. Innovations like intravesical ADCs, gene therapies, and

Great discussion and review of salvage prostatectomy data by Dr. Ashley Ross. IMO planned prolonged catheterization + cystogram is key ASCO #GU25

Day 3 #GU25 first mRCC ph3 triplet Laurence Albiges ➡️Cabo/ipi/nivo vs placebo/ipi/nivo ➡️PFS benefit 16.6 vs 11.2mo ➡️No OS diff 41.9 vs 42mo 🔺Only 1/2 got subsequent tx - TKI mostly, 10% IO, 1-3% HIF2a 🔺Underexposure of Cabo (median 22.4mg) and Ipi (58% got all 4C) in triplet arm

Excellent discussion by Clint Cary, MD MPH MBA #GU25 following Axel Heidenreich’s long term followup of COTRIMS trial. Surgery for early metastatic seminoma. Appreciate continuous efforts to improve on already excellent curative outcomes with #RPLND alone. #SEMS. Testicular Cancer Society Testicular Cancer

Phase 3 clinical trial PIVOT-006 is now enrolling patients VirginiaMasonUrology pivot006.com Happy to add cretostimogene grenadenorepvec to our armamentarium for the treatment of patients with non-muscle invasive bladder cancer

Caught up with colleagues (former Cleveland Clinic Urology alumni and Cleveland Clinic MD general surgery alumni at the Intuitive Connect conference in Orlando this past weekend. Interesting tips and tricks for the Single Port and DV5 robotic platforms! #roboticsurgery

National complication and cost burden of TURBT UCLA Urology Mayo Clinic Urology VirginiaMasonUrology Vanderbilt Urology UTMBUrology sciencedirect.com/science/articl…

Some of my personal highlights from AUA this year…impressed by cretostimogene durability data for HR BCG-unresponsive non-muscle invasive bladder cancer in a heavily pre-treated cohort #AUA2025

Very promising TAR-200 complete response rate and estimated /projected 1-2 year durability data in the CIS +/- papillary cohort. Looking forward to seeing some long term follow-up #AUA2025

So great to catch up with friends, colleagues, and mentors #AUA2025

Our Cleveland Clinic Urology residency class —now all grown up ❤️ Scott Lundy MD PhD HCLD Molly DeWitt-Foy, MD (missing Anup and Kyle)

Excited to see our paper in print European Urology: europeanurology.com/article/S0302-… Clinical Outcomes, Genomic Heterogeneity, and Therapeutic Considerations Across Histologic Subtypes of Urothelial Carcinoma

What does it mean to be a surgical oncologist? I never fully understood till I retired... shorturl.at/npRJ7

Stepping up to the plate for men's health! Virginia Mason Franciscan Health joined the Seattle Mariners at T-Mobile Park today to offer free prostate cancer screenings in honor of Men's Health Month.

Our VirginiaMasonUrology patient threw the first pitch at the Seattle Seattle Mariners game last week as a cancer survivor. Honored to join him and his family on the field for this memorable occasion. Photos by Virginia Mason and Mariners media teams